ADC Therapeutics (ADCT) Change in Account Payables (2019 - 2023)
Historic Change in Account Payables for ADC Therapeutics (ADCT) over the last 5 years, with Q4 2023 value amounting to $6.6 million.
- ADC Therapeutics' Change in Account Payables rose 201687.09% to $6.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $3.2 million, marking a year-over-year increase of 92354.84%. This contributed to the annual value of $2.5 million for FY2024, which is 2240.78% down from last year.
- Latest data reveals that ADC Therapeutics reported Change in Account Payables of $6.6 million as of Q4 2023, which was up 201687.09% from -$2.7 million recorded in Q3 2023.
- Over the past 5 years, ADC Therapeutics' Change in Account Payables peaked at $6.6 million during Q4 2023, and registered a low of -$3.7 million during Q1 2023.
- In the last 5 years, ADC Therapeutics' Change in Account Payables had a median value of $3068.0 in 2021 and averaged $584930.1.
- Examining YoY changes over the last 5 years, ADC Therapeutics' Change in Account Payables showed a top increase of 8729601.52% in 2023 and a maximum decrease of 19620702.39% in 2023.
- Over the past 5 years, ADC Therapeutics' Change in Account Payables (Quarter) stood at -$1684.0 in 2019, then surged by 313757.96% to $5.3 million in 2020, then tumbled by 99.97% to $1743.0 in 2021, then soared by 17709.01% to $310411.0 in 2022, then surged by 2016.87% to $6.6 million in 2023.
- Its last three reported values are $6.6 million in Q4 2023, -$2.7 million for Q3 2023, and $3.0 million during Q2 2023.